The US FDA/CDRH is proposing to harmonize the current Quality System Regulation (QSR) for medical devices (21 CFR 820) by converging its requirements with requirements used by many other regulatory authorities. ISO 13485, into a new device Quality Management System Regulation (QMSR).
Fax: +1-650-362-2367
This webinar will examine the 15 subparts of the Medical Device CGMPs, 21 CFR 820, the Quality System Regulation, compared againt the current version of ISO 13485:2016, with its 8 "subparts". The substantial areas of similarities will be discusses; then the areas of FDA concern and proposed solutions; and the adding in those requirements necessary to remain in alignment with the US FDA's Federal Food, Drug & Cosmetic Act.
The structure of the proposed QMSR will be discussed: 820.1 Scope; 820.3 Definitions; 820.7 Incorporation (ISO 13485:2016) by reference; 820.10 Requirements for a quality management system - Links additional FDA requirements such as MDR, UDI, Corrections & Removals, and Tracking; applicability of Design and Development activities; 820.15 Clarification of concepts - Correlates concepts in ISO 13485 to FDA; 820.35 Control of records - Supplements record keeping activities, signature and date, complaint / servicing records, UDI, and confidentiality; and 820.45 Device labeling and packaging controls. The primary areas of differences: Document Control, Labeling and Packaging Control, Records, and Servicing. These will be discussed in the webinar as well. There will be a one-year transition period.
Why Should You Attend:FDA/CDRH is proposing to harmonize the current Quality System (QS) regulation for medical devices (21 CFR 820) by converging its requirements with requirements used by many other regulatory authorities. Revisions to Part 820 will replace most of the existing regulation with an incorporation by reference (IBR) to the 2016 edition of" ISO 13485 - Medical Devices - Quality Management Systems Requirements for Regulatory Purposes". The requirements in ISO 13485:2016 are substantially similar to the current requirements of Part 820, the QSR. Differences will be explained or reconciled, and the few areas where ISO 13485 is considered weak by the FDA will be strengthened in the proposed US QMSR.
Areas Covered in the Webinar:Principal, J E Lincoln and Associates
John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 36 years’ experience in U.S. FDA-regulated industries, 22 as a full-time consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. John is a graduate of UCLA.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.
Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.
If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.
We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).
This product hasn't received any reviews yet. Be the first to review this product! Write review